Antabio's Grant - III Round

Antabio raised a round of funding on February 01, 2013. Investors include Wellcome Trust.

Antabio is a biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need.…

Articles about Antabio's Grant - III Round: